Person
Scott Gottlieb
This page collects what Scott Gottlieb said on two podcasts, The a16z Show and Freakonomics, M.D., about the COVID-19 pandemic and how the US should prepare for the next one. Topics include testing, vaccines, nursing homes, stockpiles and flu.
Gottlieb told The a16z Show that the FDA required full trial data before authorizing COVID-19 vaccines, and that the Pfizer and Moderna trials each enrolled about 45,000 patients. On Freakonomics, M.D., he said a lack of diagnostic testing led officials to overestimate the role of contaminated surfaces. Each fact below includes his exact quote and a link to the moment.
2 episodes · 37 quoted claims
Gottlieb says flu vaccine sequences must undergo egg adaptation because flu vaccines are manufactured in eggs, which can change the protein.
“With a flu vaccine, as you move from vaccine to vaccine, that sequence has to undergo egg adaptation because the vaccines are manufactured in eggs.”
The a16z Show · 0:03:09
Gottlieb says the emergency use authorization pathway originated in Project BioShield, post-9/11 legislation for rapid authorization of countermeasures to bioterrorist attacks.
“The emergency use authorization, which was originally derived in Project BioShield, it was sort of post-9 -11 legislation on how to create a pathway for the rapid regulatory authorization”
The a16z Show · 0:08:38
Gottlieb says that in winter the US was losing about 7,000 people a week in nursing homes to COVID-19.
“because at the point in the wintertime, we were losing 7 ,000 people a week in nursing homes. That's where the extreme death and disease was.”
The a16z Show · 0:09:44
Gottlieb says the FDA required the full trial data set and two months of follow-up on half the patients before authorizing COVID-19 vaccines.
“the FDA moved towards a posture where they required the full data set and two months of follow-up on 50 % of the patients in the clinical trial before they would authorize the vaccines.”
The a16z Show · 0:10:15
Gottlieb says the Pfizer and Moderna COVID-19 vaccine trials each enrolled about 45,000 patients.
“Each trial, the Pfizer and the Moderna trial, each trial was about 45 ,000 patients.”
The a16z Show · 0:16:10
Gottlieb recalls that the largest vaccine trial he knew of at the FDA was a rotavirus vaccine trial of around 60,000 patients.
“The largest vaccine trial I remember from being at FDA was the rotavirus vaccine. I think it was around 60 ,000 patients.”
The a16z Show · 0:16:35
Gottlieb says Pfizer pivoted quickly to a COVID-19 vaccine because it was already using the mRNA platform to develop a flu vaccine.
“In fact, the reason why Pfizer was able to pivot so quickly was that they were trying to use this platform to develop a flu vaccine.”
The a16z Show · 0:17:50
Gottlieb discloses a board role at Illumina, a maker of DNA sequencing machines, alongside his Pfizer board role.
“Illumina, which is one of the companies that makes sequencing machines that's used by a lot of laboratories here and abroad.”
The a16z Show · 0:20:28
Gottlieb says genetic epidemiology had previously been used at any scale for an outbreak response only during the Ebola epidemic in West Africa.
“The only place that you saw genetic epidemiology used at any scale to help inform the response to an outbreak or an epidemic was in the context of Ebola in West Africa.”
The a16z Show · 0:21:27
Gottlieb says CDC under-reported US virus sequencing because it did not count sequences from academic and commercial labs that did not follow its protocol.
“the answer was because CDC wouldn't recognize the sequences that were being done in a lot of academic and commercial labs because they weren't being done according to CDC's protocol.”
The a16z Show · 0:25:47
Gottlieb says the roughly 100 US public health labs could each process about 100 samples a day, about 10,000 tests daily in total.
“the 100 public health labs in this country can each process about 100 samples a day on average. So you're talking about a capacity of 10 ,000 tests a day”
The a16z Show · 0:31:47
Gottlieb says D.A. Henderson, a public health official who helped eradicate smallpox, was a vocal critic of population-wide pandemic mitigation measures.
“D.A. Henderson, the famed public health official who helped eradicate smallpox, was one of the most vocal critics of mitigation.”
The a16z Show · 0:34:40
Gottlieb says the US pandemic response tactics were derived from H5N1 pandemic planning, producing a flu-based plan for COVID-19.
“it was pandemic planning done around H5N1. So we adopted a very flu-based plan in response to COVID.”
The a16z Show · 0:34:40
Gottlieb says the US enrolled over 100 studies of hydroxychloroquine when one definitive study would have sufficed.
“We probably enrolled over 100 studies to examine hydroxychloroquine. We should have really only had one definitive study enrolled at the outset to examine that.”
The a16z Show · 0:37:22
Gottlieb says the British RECOVERY trial, a single coordinated study, produced many of the most important early answers on which COVID-19 therapies worked.
“The British did that with recovery. And in fact, many of the most important answers around what therapies worked and didn't work early on actually came from that single British study.”
The a16z Show · 0:37:49
Gottlieb says CDC first proposed 10 feet of physical distancing to the White House before settling on six feet after objections from the Office of Management and Budget.
“The CDC came to the White House, this is back in the beginning, with a recommendation that they wanted to have 10 feet of physical distance as the recommendation.”
The a16z Show · 0:41:16
Gottlieb says the US tried building a standby manufacturing plant with Emergent and found that an idle plant is not kept up to date.
“We tried that with Emergent and we saw that if you build a plant and you're not operating it continuously, you know, it's not kept up to date.”
The a16z Show · 0:44:51
Gottlieb proposes that high-complexity labs run more machines at lower utilization, such as 5,000 at 50 to 60 percent instead of 3,000 at 80 percent, to keep reserve capacity.
“A high complexity lab might have 3 ,000 machines that are running at 80 % capacity. Maybe what we should really have is 5 ,000 machines running at 50 % capacity or 60 % capacity.”
The a16z Show · 0:43:50
Gottlieb says the 2017-2018 flu vaccine was only about 25 percent protective against the predominant influenza strain that season.
“It was only 25 % protective against the predominant strain of influenza in that season.”
The a16z Show · 0:48:24
Gottlieb says CDC estimated about 60,000 flu deaths in 2017-2018 from a model, with a confidence interval of roughly 40,000 to 120,000.
“if I remember correctly, it was something like 60 ,000 was the estimate. But if you actually looked at it, the confidence interval was like 40 ,000 to 120 ,000”
The a16z Show · 0:49:13
Gottlieb says diagnostic makers told him they had developed Zika tests at the government's urging, then were not reimbursed, which made them slow to pivot to COVID-19 tests.
“the government told us we should be developing tests for Zika. Zika turned out to be, you know, less pervasive than what we initially feared.”
The a16z Show · 0:50:58
Scott Gottlieb says that around Martin Luther King Day in January 2020, the cases China reported overnight rose from about 50 to about 200.
“overnight, the cases that China was reporting had quadrupled. So it had gone from something like 50 to 200.”
Freakonomics, M.D. · 0:05:46
Scott Gottlieb says South Korea had set up procedures to hand testing quickly to commercial manufacturers after its experience with MERS.
“they had put in place procedures for a very rapid handoff to their commercial manufacturers to scale up testing after their very devastating experience with MERS.”
Freakonomics, M.D. · 0:09:17
Scott Gottlieb says the lack of diagnostic testing led officials to overestimate the role of contaminated surfaces in spreading Covid-19.
“We couldn't identify how spread was occurring, So we overestimated the role of contaminated surfaces.”
Freakonomics, M.D. · 0:09:42
Scott Gottlieb says the US ended up doing a simultaneous 14-day nationwide shutdown because officials did not know where the virus was spreading.
“we ended up having to do a simultaneous shutdown of 14 days to slow the spread across the whole country because we didn't know where it was and wasn't spreading.”
Freakonomics, M.D. · 0:10:08
Scott Gottlieb says stockpiled ventilators did not work and stockpiled N95 masks had brittle bands because they had been stored poorly.
“the best metaphor for that were the ventilators that didn't work or the N95 masks where the band broke when people put it on because it had become brittle because it hadn't been stored properly”
Freakonomics, M.D. · 0:11:25
Scott Gottlieb says that during the H1N1 swine flu pandemic other countries nationalized supplies the US needed.
“We had seen with H1N1, for example, the swine flu, other countries nationalized some of the supplies that we needed to combat that pandemic.”
Freakonomics, M.D. · 0:12:28
Scott Gottlieb says that in the 2015 Ebola crisis in West Africa, a response was mobilized only once the US Department of Defense arrived.
“in 2015, during the Ebola crisis in West Africa, it wasn't until the DOD went in on the ground that you really started to mobilize a response.”
Freakonomics, M.D. · 0:14:50
Scott Gottlieb says Congress first created the emergency use authorization framework for bioterrorism and later broadened it to pandemics through the Pandemic All Hazards Preparedness Act.
“Congress initially they created it to address an act of bioterrorism, but it was broadened to address pandemic risks as well in the Pandemic All Hazards Preparedness Act.”
Freakonomics, M.D. · 0:16:41
Scott Gottlieb says that early in the pandemic about half of Covid deaths were occurring in nursing homes.
“because you know that half the deaths are occurring in nursing homes.”
Freakonomics, M.D. · 0:17:19
Scott Gottlieb says Moderna has said it developed its vaccine without ever having the virus in its laboratories.
“Moderna, they talk about the fact that they never had the virus actually in their laboratories.”
Freakonomics, M.D. · 0:23:01
Scott Gottlieb says the Covid-19 vaccines could be designed so quickly because they were made synthetically from genetic sequence data alone.
“The reason why we were able to come up with these vaccine constructs so quickly was because they were synthetically derived from sequence data alone.”
Freakonomics, M.D. · 0:23:01
Scott Gottlieb says the old approach of building a vaccine facility and partly mothballing it did not work well for scaling up in a crisis.
“The old notion was we'll build a facility, we'll partially mothball it, which didn't work so well”
Freakonomics, M.D. · 0:23:32
Scott Gottlieb says most of the important answers about Covid therapeutics came from the single British Recovery trial.
“all of the important answers or most of the important answers we got about COVID therapeutics came from that single trial”
Freakonomics, M.D. · 0:24:43
Scott Gottlieb says countries have concealed information about outbreaks, so international agreements alone cannot be trusted for disease surveillance.
“countries conceal information. Countries have not been forthcoming with information about outbreaks.”
Freakonomics, M.D. · 0:25:38
Scott Gottlieb predicted that after the Delta wave, the population would have a very high rate of immunity from vaccination or prior infection.
“After this delta wave is finished coursing its way through the population, you're going to have a very high rate of immunity in the population”
Freakonomics, M.D. · 0:30:41
Scott Gottlieb says US pandemic stockpiling was designed mainly around influenza, the pathogen planners most feared.
“we had stockpiled some of what we needed for a pandemic with flu. The pathogen that we always feared was a flu.”
Freakonomics, M.D. · 0:11:14